The use of Teflon cell culture bags to expand functionally active CD8+ cytotoxic T lymphocytes

Journal of Immunological Methods

Volumn 227, Issue 1-2, 1999, Pages 53-63

  Garland, R J ^a   Kaneria, S S ^a   Hancock, J P ^a   Steward, C G ^a,b   Rowbottom, A W ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

Bag; CD8; Expansion; Human; Teflon

Indexed keywords

CD18 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; FAS ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; POLITEF; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL COUNT; CELL CULTURE; CELL CYCLE; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOBLASTOID CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TIME;

CELL CULTURE TECHNIQUES; CELL CYCLE; HUMANS; IMMUNOPHENOTYPING; POLYTETRAFLUOROETHYLENE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032820542     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00068-X     Document Type: Article

References (21)

1. Aebersold P., Carter C.S., Hyatt C., Johnson S., Ottaway K., Leitman S.F., Rosenberg S.A. A simplified automated procedure for generation of human lymphokine-activated killer cells for use in clinical trials. J. Immunol. Methods. 112:1988;1.
2. Brucker C., Reimann J., Wagner H., Kabelitz D. Clonal activation of cytotoxic lymphocyte precursors by monoclonal anti-CD3 antibody: analysis of feeder cell requirements. Immunol. Lett. 14:1987;121.
3. Chai J.G., Bartok I., Scott D., Dyson J., Lechler R. T:T antigen presentation by activated murine CD8+T cells induces anergy and apoptosis. J. Immunol. 160:1998;3655.
4. Coulon V., Ravaud A., Huet S., Gualde N. In vitro production of human antigen presenting cells issued from bone marrow of patients with cancer. Hematol. Cell Ther. 39:1997;237.
5. Hromas R., Cornetta K., Srour E., Blanke C., Broun E.R. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood. 84:1994;1689.
6. Itoh K., Platsoucas C.D., Balch C.M. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J. Exp. Med. 168:1988;1419.
7. Lamers C.H., Van de Griend R.J., Braakman E., Ronteltap C.P., Benard J., Stoter G., Gratama J.W., Bolhuis R.L. Optimization of culture conditions for activation and large-scale expansion of human T lymphocytes for bispecific antibody-directed cellular immunotherapy. Int. J. Cancer. 51:1992;973.
8. Lowdell M.W., Ray N., Craston R., Corbett T., Deane M., Prentice H.G. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia. Bone Marrow Transplant. 19:1997;891.
9. Mackinnon S., Papadopoulos E.B., Carabasi M.H., Reich L., Collins N.H., Boulad F., CastroMalaspina H., Childs B.H., Gillio A.P., Kernan N.A., Small T.N., Young J.W., OReilly R.J. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood. 86:1995;1261.
10. Moretta A., Pantaleo G., Moretta L., Cerottini J.C., Mingari M.C. Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J. Exp. Med. 157:1983;743.
11. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271.
12. Papadopoulos E.B., Ladanyi M., Emanuel D., Mackinnon S., Boulad F., Carabasi M.H., CastroMalaspina H., Childs B.H., Gillio A.P., Small T.N., Young J.W., Kernan N.A., OReilly R.J. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330:1994;1185.
13. Purdy M.H., Hogan C.J., Hami L., McNiece I., Franklin W., Jones R.B., Bearman S.I., Berenson R.J., Cagnoni P.J., Heimfeld S. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. J. Hematother. 4:1995;515.
14. Riddell S.R., Greenberg P.D. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Methods. 128:1990;189.
15. Riddell S.R., Watanabe K.S., Goodrich J.M., Li C.R., Agha M.E., Greenberg P.D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257:1992;238.
16. Rosenberg S. Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. J. Natl. Cancer Inst. 75:1985;595.
17. Rosenberg S.A., Packard B.S., Aebersold P.M., Solomon D., Topalian S.L., Toy S.T., Simon P., Lotze M.T., Yang J.C., Seipp C.A. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N. Engl. J. Med. 319:1988;1676.
18. Sperber K., Bauer J., Pizzimenti A., Najfeld V., Mayer L. Identification of subpopulations of human macrophages through the generation of human macrophage hybridomas. J. Immunol. Methods. 129:1990;31.
19. Valiante N.M., Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178:1993;1397.
20. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1995;1038.
21. Wolthers K.C., Otto S.A., Lens S.M., Kolbach D.N., van L.R., Miedema F., Meyaard L. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+T cells. Eur. J. Immunol. 26:1996;1700.